1. Home
  2. DYN vs PDO Comparison

DYN vs PDO Comparison

Compare DYN & PDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYN
  • PDO
  • Stock Information
  • Founded
  • DYN 1984
  • PDO 2020
  • Country
  • DYN United States
  • PDO United States
  • Employees
  • DYN N/A
  • PDO N/A
  • Industry
  • DYN Medicinal Chemicals and Botanical Products
  • PDO Trusts Except Educational Religious and Charitable
  • Sector
  • DYN Health Care
  • PDO Finance
  • Exchange
  • DYN Nasdaq
  • PDO Nasdaq
  • Market Cap
  • DYN 1.9B
  • PDO 1.7B
  • IPO Year
  • DYN 2020
  • PDO N/A
  • Fundamental
  • Price
  • DYN $14.51
  • PDO N/A
  • Analyst Decision
  • DYN Strong Buy
  • PDO
  • Analyst Count
  • DYN 14
  • PDO 0
  • Target Price
  • DYN $34.93
  • PDO N/A
  • AVG Volume (30 Days)
  • DYN 2.5M
  • PDO 520.0K
  • Earning Date
  • DYN 11-11-2025
  • PDO 01-01-0001
  • Dividend Yield
  • DYN N/A
  • PDO 11.80%
  • EPS Growth
  • DYN N/A
  • PDO N/A
  • EPS
  • DYN N/A
  • PDO N/A
  • Revenue
  • DYN N/A
  • PDO N/A
  • Revenue This Year
  • DYN N/A
  • PDO N/A
  • Revenue Next Year
  • DYN N/A
  • PDO N/A
  • P/E Ratio
  • DYN N/A
  • PDO N/A
  • Revenue Growth
  • DYN N/A
  • PDO N/A
  • 52 Week Low
  • DYN $6.36
  • PDO $10.65
  • 52 Week High
  • DYN $35.90
  • PDO $13.31
  • Technical
  • Relative Strength Index (RSI)
  • DYN 59.18
  • PDO 77.87
  • Support Level
  • DYN $12.43
  • PDO $14.06
  • Resistance Level
  • DYN $14.27
  • PDO $14.02
  • Average True Range (ATR)
  • DYN 0.73
  • PDO 0.06
  • MACD
  • DYN 0.04
  • PDO 0.01
  • Stochastic Oscillator
  • DYN 85.53
  • PDO 92.42

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

About PDO PIMCO Dynamic Income Opportunities Fund of Beneficial Interest

PIMCO Dynamic Income Opportunities Fund is a closed-end management investment company. The fund's primary investment objective is to generate a level of income that is higher than that generated by high-quality, intermediate-term U.S. debt securities.

Share on Social Networks: